From a clinical point of view, CD49d has been identified as an independent negative prognosticator for CLL, marking a subset of CLL patients characterized by aggressive and accelerated clinical course [8,150-152]. Here, ITGA4 is linked to B-cell chronic lymphocytic leukemia.